15 Aug 2016
Immunity to tuberculosis: From Bench to Bed and Back Again
18 Aug 2016
Visiting guest speaker Professor Stefan Kaufmann from the Max Planck Institute in Berlin will present on Immunity to tuberculosis: from bench to bed and back again.
Tuberculosis remains a major health threat with 9.6 million cases and 1.5 million deaths in 2014. At this presentation, Professor Kaufmann provide an update on his TB vaccine candidate VPM1002 and will summarise his most recent biomarker research that has led to a diagnostic point-of-care biosignature for TB and recent attempts to define a prognostic biosignature, which can identify the risk of TB.
As founding Director of the Max Planck Institute for Infection Biology in Berlin, Professor Kaufmann heads the Department of Immunology and Professor for Microbiology & Immunology and the Charitè University Clinics in Berlin. He holds a Doctor Honoris Causa from the Université de la Mediterranée, Aix-Marseille II. His scientific interests include immunity to TB and rational design of vaccines and biosignature. He is coordinator of several international and interdisciplinary projects including Grand Challenge 6 of the Bill & Melinda Gates Foundation, which amis to identify a prognostic biosignature for risk of tuberculosis.